Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
initiative, established in 2024, is a collaboration between the University of Oxford and GlaxoSmithKline (GSK) aimed at identifying molecular vulnerabilities in precancers and developing targeted interventions
-
with different diseases in diverse populations and to identify potential therapeutic targets. This is an exciting opportunity to contribute to a programme of research that assess the causal relevance
-
proteins as antiviral targets, at the Centre for Medicines Discovery, Nuffield Department of Medicine. You will be responsible for running and managing a set of projects involving integral membrane proteins
-
approaches including targeted genetic murine models, primary cell culture and analysis, multi-omics and bioinformatics. The biological focus will be on vascular biology, immune cell function and metabolism
-
. Target fundamental mechanisms with clear translational relevance to cancer, heart diseases and other developmental and neurological diseases. Applications for this vacancy should be made online and you
-
Light Source synchrotron, and Imperial College London. Target fundamental mechanisms with clear translational relevance to diabetes, obesity, and metabolic disorders. Applications for this vacancy should
-
We have an opportunity to recruit a Laboratory Technician to join the Song research group withing the Target Discovery Institute, Nuffield Department of Medicine. The Song research group aims
-
various channels, setting targets, and monitoring progress. You will also have the opportunity to prepare compelling applications to secure funding from trusts, foundations, and government bodies. You will
-
across private and public sectors to promote the Department's Statistical Consultancy Services and proactively identify new opportunities for service provision. In addition to targeting external clients
-
in preventing immune-mediated pathology in autoimmunity remains poorly understood. Using genetic and antibody-based targeting, we aim to dissect how these pathways modulate T-cell signalling